Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Docetaxel and exisulind in hormone-refractory prostate cancer.

Ryan CW, Stadler WM, Vogelzang NJ. Docetaxel and exisulind in hormone-refractory prostate cancer. Semin Oncol. 2001 Aug; 28(4 Suppl 15):56-61.

View in: PubMed

collapse authors with profiles